WO2008099911A1 - 保存安定性に優れた広域抗ウイルス薬剤組成物 - Google Patents

保存安定性に優れた広域抗ウイルス薬剤組成物 Download PDF

Info

Publication number
WO2008099911A1
WO2008099911A1 PCT/JP2008/052493 JP2008052493W WO2008099911A1 WO 2008099911 A1 WO2008099911 A1 WO 2008099911A1 JP 2008052493 W JP2008052493 W JP 2008052493W WO 2008099911 A1 WO2008099911 A1 WO 2008099911A1
Authority
WO
WIPO (PCT)
Prior art keywords
broad
storage stability
excellent storage
antiviral composition
spectrum antiviral
Prior art date
Application number
PCT/JP2008/052493
Other languages
English (en)
French (fr)
Inventor
Toshiaki Fukuda
Koji Abe
Takashi Shibata
Original Assignee
Taiko Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiko Pharmaceutical Co., Ltd. filed Critical Taiko Pharmaceutical Co., Ltd.
Priority to JP2008558142A priority Critical patent/JP4598130B2/ja
Priority to EP08711323A priority patent/EP2130542A4/en
Priority to CN200880004959.5A priority patent/CN101610778B/zh
Priority to US12/527,338 priority patent/US8545898B2/en
Priority to CA2678151A priority patent/CA2678151C/en
Priority to KR20097017598A priority patent/KR101489011B1/ko
Publication of WO2008099911A1 publication Critical patent/WO2008099911A1/ja
Priority to HK10106089.7A priority patent/HK1139325A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

　溶存二酸化塩素ガス、亜塩素酸塩、及びｐＨ調整剤を構成成分に有する純粋二酸化塩素液剤からなることを特徴とする保存安定性に優れた広域抗ウイルス薬剤組成物。
PCT/JP2008/052493 2007-02-16 2008-02-15 保存安定性に優れた広域抗ウイルス薬剤組成物 WO2008099911A1 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2008558142A JP4598130B2 (ja) 2007-02-16 2008-02-15 保存安定性に優れた広域抗ウイルス薬剤組成物
EP08711323A EP2130542A4 (en) 2007-02-16 2008-02-15 BROAD SPECTRUM ANTIVIRAL COMPOSITION HAVING EXCELLENT STORAGE STABILITY
CN200880004959.5A CN101610778B (zh) 2007-02-16 2008-02-15 保存稳定性优异的广谱抗病毒药剂组合物
US12/527,338 US8545898B2 (en) 2007-02-16 2008-02-15 Broad-spectrum antiviral composition with excellent preservation stabilty
CA2678151A CA2678151C (en) 2007-02-16 2008-02-15 Broad-spectrum antiviral composition with excellent preservation stability
KR20097017598A KR101489011B1 (ko) 2007-02-16 2008-02-15 보존 안정성이 뛰어난 광역 항바이러스 약제 조성물
HK10106089.7A HK1139325A1 (en) 2007-02-16 2010-06-18 Broad-spectrum antiviral composition having excellent storage stability

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-036469 2007-02-16
JP2007036469 2007-02-16

Publications (1)

Publication Number Publication Date
WO2008099911A1 true WO2008099911A1 (ja) 2008-08-21

Family

ID=39690136

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/052493 WO2008099911A1 (ja) 2007-02-16 2008-02-15 保存安定性に優れた広域抗ウイルス薬剤組成物

Country Status (9)

Country Link
US (1) US8545898B2 (ja)
EP (1) EP2130542A4 (ja)
JP (1) JP4598130B2 (ja)
KR (1) KR101489011B1 (ja)
CN (2) CN104083401B (ja)
CA (1) CA2678151C (ja)
HK (2) HK1139325A1 (ja)
TW (1) TWI444191B (ja)
WO (1) WO2008099911A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016526036A (ja) * 2013-05-20 2016-09-01 本部三慶株式会社 亜塩素酸水含有ウイルス殺傷剤
WO2021250907A1 (ja) * 2020-06-08 2021-12-16 株式会社ピーアンドエス 滅菌剤

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1863502B1 (en) 2005-03-23 2018-09-12 Sonoma Pharmaceuticals, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
US8147444B2 (en) 2006-01-20 2012-04-03 Oculus Innovative Sciences, Inc. Methods of treating or preventing peritonitis with oxidative reductive potential water solution
EP2130795A4 (en) * 2007-03-15 2012-12-19 Taiko Pharmaceutical Co Ltd COMPOSITION FOR STABILIZING CHLORIDE DIOXIDE
US20110052725A1 (en) * 2007-03-27 2011-03-03 Takashi Shibata Therapeutic agent for infectious skin and mucosal disease
WO2010009063A2 (en) 2008-07-15 2010-01-21 Basf Corporation Non-cytotoxic chlorine dioxide fluids
US8311625B2 (en) 2009-02-04 2012-11-13 Basf Corporation Chlorine dioxide treatment for biological tissue
CA2761710C (en) * 2009-05-11 2019-10-01 Oculus Innovative Sciences, Inc. Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
CA2765696C (en) 2009-06-15 2018-03-06 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
KR101314557B1 (ko) * 2011-02-16 2013-10-04 김창현 가축의 바이러스성 질환의 치료 또는 예방 방법
EP3085663B1 (en) * 2013-12-20 2024-01-17 Honbu Sankei Co., Ltd. Method for producing aqueous chlorous acid by adsorption of chlorine dioxide
CN104666330B (zh) * 2015-03-17 2018-03-16 深圳市仝森林科技有限公司 纯二氧化氯溶液制备内用消毒剂的应用
RU2698182C1 (ru) 2016-07-28 2019-08-22 Эксион Лэбс Инк. Антимикробные композиции на полимерной основе и способ их применения
CA3097998A1 (en) 2018-04-27 2019-10-31 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
KR102300013B1 (ko) * 2020-02-11 2021-09-08 주식회사 리우물산 코로나 바이러스를 사멸하는 이산화염소 서방출성 제품 및 이를 제조하는 방법
WO2021162171A1 (ko) * 2020-02-11 2021-08-19 주식회사 클로바이오 이산화염소 방출 스티커의 제조방법 및 이산화염소 방출 스티커

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6140803A (ja) 1984-07-31 1986-02-27 Oriental Yakuhin Kogyo Kk 凝固状二酸化塩素発生組成物及びその包装体
JPS61181532A (ja) 1985-02-07 1986-08-14 Miura Kagaku Sochi Kk 安定化二酸化塩素を含有するゲル状組成物
JPH11278808A (ja) * 1997-11-28 1999-10-12 Business Plan Kk 純粋二酸化塩素液剤、これを含有するゲル状組成物及び発泡性組成物、並びに、これらを入れるための容器
US6200557B1 (en) * 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950500A (en) * 1975-01-21 1976-04-13 Hooker Chemicals & Plastics Corporation Method of producing chlorine dioxide
JP3004958B2 (ja) * 1998-02-19 2000-01-31 クリーンケミカル株式会社 殺菌消毒用製剤
CL2002002762A1 (es) 2002-12-02 2005-01-14 Protecsa S A Proceso para obtener una solucion de dioxido de cloro acuoso.
CN1964916A (zh) * 2004-04-23 2007-05-16 安全固体方案公司 温度稳定性增加且可释放二氧化氯的固体组合物及其输送方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6140803A (ja) 1984-07-31 1986-02-27 Oriental Yakuhin Kogyo Kk 凝固状二酸化塩素発生組成物及びその包装体
JPS61181532A (ja) 1985-02-07 1986-08-14 Miura Kagaku Sochi Kk 安定化二酸化塩素を含有するゲル状組成物
US6200557B1 (en) * 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
JPH11278808A (ja) * 1997-11-28 1999-10-12 Business Plan Kk 純粋二酸化塩素液剤、これを含有するゲル状組成物及び発泡性組成物、並びに、これらを入れるための容器
JP3110724B2 (ja) 1997-11-28 2000-11-20 ビジネスプラン株式会社 純粋二酸化塩素液剤、これを含有するゲル状組成物及び発泡性組成物、並びに、これらを入れるための容器

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN Y.S. ET AL.: "Inactivation of Human and Simian Rotaviruses by Chlorine Dioxide", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 56, no. 5, 1990, pages 1363 - 1366, XP008112238 *
LI J.W. ET AL.: "Mechanisms of inactivation of hepatitis A virusin water by chlorine dioxide", WATER RESEARCH, vol. 38, no. 6, 2004, pages 1514 - 1519, XP004494468 *
See also references of EP2130542A4

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016526036A (ja) * 2013-05-20 2016-09-01 本部三慶株式会社 亜塩素酸水含有ウイルス殺傷剤
WO2021250907A1 (ja) * 2020-06-08 2021-12-16 株式会社ピーアンドエス 滅菌剤

Also Published As

Publication number Publication date
KR101489011B1 (ko) 2015-02-02
HK1201465A1 (en) 2015-09-04
CA2678151A1 (en) 2008-08-21
TWI444191B (zh) 2014-07-11
US8545898B2 (en) 2013-10-01
KR20090114411A (ko) 2009-11-03
JP4598130B2 (ja) 2010-12-15
JPWO2008099911A1 (ja) 2010-05-27
CN101610778B (zh) 2015-08-05
CN104083401A (zh) 2014-10-08
CN104083401B (zh) 2017-04-12
TW200906425A (en) 2009-02-16
CN101610778A (zh) 2009-12-23
EP2130542A1 (en) 2009-12-09
US20100028456A1 (en) 2010-02-04
CA2678151C (en) 2015-06-16
HK1139325A1 (en) 2010-09-17
EP2130542A4 (en) 2010-06-02

Similar Documents

Publication Publication Date Title
WO2008099911A1 (ja) 保存安定性に優れた広域抗ウイルス薬剤組成物
WO2008111357A1 (ja) 純粋二酸化塩素液剤、これを含有するゲル状組成物及び発泡性組成物
WO2007042321A3 (en) Kinase inhibitors
WO2008111358A1 (ja) 二酸化塩素用の安定化組成物
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
WO2007061737A3 (en) FUSED BICYCLIC mTOR INHIBITORS
WO2008153159A1 (ja) アミン化合物及びその医薬用途
WO2007014054A3 (en) Benzenesulfonamide inhibitor of ccr2 chemokine receptor
WO2008116815A3 (en) Compounds
WO2007121924A3 (en) Bisadenosine compounds as adenosine a2a receptor agonists
EP1864665A4 (en) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
WO2006112549A8 (ja) 縮合複素環化合物
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2007053736A3 (en) Azeotrope compositions comprising 2,3,3,3-tetrafluoropropene and hydrogen fluoride and uses thereof
WO2009054479A1 (ja) スピロ環化合物及びその医薬用途
WO2008009700A8 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
EP1998713A4 (en) NON-INVASIVE DEVICES, SYSTEMS AND METHODS FOR REDUCING PULMONARY VOLUME
DK2074122T3 (da) Pyrido (2, 3-D) pyrimidinon-forbindelser og anvendelse deraf som P13 inhibitorer
WO2008142055A3 (en) Antiviral agents
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2006041631A3 (en) Novel cyclosporin alkynes and their utility as pharmaceutical agents
WO2007078838A3 (en) Solid biocide composition and sealed biocide article
WO2009113092A3 (en) Process for preparation of proguanil hydrochloride
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2009020137A1 (ja) アミノピラゾールアミド誘導体

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880004959.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711323

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2008558142

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2678151

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1020097017598

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2008711323

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 5469/CHENP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12527338

Country of ref document: US